Tesamorelin

£90.00

Synthetic GHRH analogue | Endocrine & metabolic research

Tesamorelin is supplied as a high-purity, lyophilised synthetic peptide, intended exclusively for laboratory research use. It is a modified analogue of growth hormone-releasing hormone (GHRH) and is handled in controlled research environments for endocrine and metabolic studies only.

This compound is not approved for human or veterinary use.

Specification: 10mg × 30 vials

Category:

Chemical & physical information

Molecular formula: C221H366N72O67S
Molecular weight: ~5135.9 g/mol

Amino acid sequence:
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Ser-Ala-Arg-Lys-Leu-Leu- Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-NH2

Form: Lyophilised powder
Typical purity: ≥99%

Research context
Tesamorelin is extensively studied in growth hormone signalling and metabolic regulation research. Its enhanced stability compared to endogenous GHRH makes it useful in laboratory models investigating:

  • GHRH receptor activation
  • Growth hormone release mechanisms
  • Endocrine feedback loops
  • Metabolic and body-composition signalling pathways

Researchers often select Tesamorelin for controlled mechanistic studies where prolonged receptor interaction and reproducibility are required.

Quality & handling

Supplied as a lyophilised solid for laboratory research

High analytical purity verified by chromatographic analysis
Batch-specific documentation available

For research use only

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin”

Your email address will not be published. Required fields are marked *